Tuesday, September 02, 2014 7:55:07 AM
your quote "The pancreatic tissue regrowth has immense marketing capability for Type II diabetes" is inaccurate at best.
Type I Diabetics pancrease no longer work and they are dependant on insulin injects.
Type II Diabetics pancrease still works; however, it no longer produces a sufficent amounnt of insulin.
As a person that has Type I diabetes I am well versed on the subject.
In addition, they have already successfully regenerated pancreated tissue by using the cells of a deceased persons pancrease and injecting them into a Type I diabetics pancrease.
This however, does not cure Type 1 Diabeties. As is the case when a person first becomes Type 1 diabetic, as soon as their pancrease begins to generate insulin, their immune system immediatly attacks their pancrease and kills it again. It is unknown why this happens initially and why it continues to happen after the pancrease is healed/regenereated.
They only way they can stop this from happening is by requiring the patient to take immune suppression injections for the remained of their life.
So its a trade off, take insulin injections and have diabetic complications, or regenerate your pancrease but take immune suppression injections and be sick all the time.
So, long stoty made short, your statement is incorrect in regards to what TCEL has the capability of fixing.
TCEL may, i repeate MAY, have some usefullness if they ever bring anything to market....but that remains to be seen.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM